Delivery Order SPE2DB25D7067-SPE2DB25FSWBE
- Not listed
- The U.S. Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of MOVIPREP Powder Packets. The $1,947.30 award does not have a set-aside designation and is part of an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This single...
- The Defense Logistics Agency awarded a $3,414.82 delivery order to AmerisourceBergen Drug Corp for MOVIPREP Powder Packets under a firm fixed price contract. The award, issued on May 27, 2025, with an ultimate completion date of May 28, 2025, represents a non-competitive delivery order issued without set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, with a potential value of $1,413.76, is for the provision of MOVIPREP POWDER PACKETS to be delivered by February 9, 2024. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of up to...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a firm fixed-price delivery order from the Defense Logistics Agency (DLA) valued at $1,233.66 for MOVIPREP powder packets. Awarded on September 15, 2025, with an ultimate completion date of September 16, 2025, this non-set-aside contract represents a small-value procurement from DLA's broader medical supply operations. The delivery order is performed at the contractor's...
- This federal contract award, valued at $3,214.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOVIPREP POWDER PACKETS and has an ultimate completion date of April 14, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and is not associated with any set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is not set aside, has a ceiling value of $1,709.58 and a completion date of June 30, 2025. The award is for the supply of MOVIPREP POWDER PACKETS, a medical product. Amerisourcebergen Drug Corp is the prime contractor and there are no major subcontractors mentioned. This...
- This federal contract award, valued at $2,462.95, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOVIPREP POWDER PACKETS, a medical supply product, and has an ultimate completion date of September 20, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MOVIPREP powder packets valued at $6,479.70 under a firm fixed price contract. The award was made on May 20, 2025, with an ultimate completion date of May 21, 2025, and represents a non-set-aside competitive award. MOVIPREP is a bowel preparation medication used prior to colonoscopy procedures, indicating this delivery supports medical supply needs for federal healthcare systems, likely serving military...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,584.44 Firm Fixed Price Delivery Order is for the supply of MOVIPREP POWDER PACKETS, with a period of performance through April 1, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a wholly owned subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The contract is for the supply of MOVIPREP POWDER PACKETS, a pharmaceutical product, with a potential value of $3,467.31 and a completion date of March 8, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely...
- SPE2DB25D7067Indefinite Delivery Contract
- SPE2DB25D7067-SPE2DB25FSWBEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,036.32 to AmerisourceBergen Drug Corp for MOVIPREP powder packets, a bowel preparation medication commonly used in medical procedures. This firm fixed price contract, awarded on September 16, 2025, with an ultimate completion date of September 17, 2025, represents a small-value transaction executed through the company's existing contract vehicle. The award was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The parent IDC serves as a global pharmaceutical support vehicle enabling the company to fulfill medical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 9/16/25 |